. 2021 Feb 26;142(7):1459–1467. doi: 10.1007/s00402-021-03824-0

Table 3.

Mean Katz ADL scores for patients treated with a DHS and PFNA

Time	Implant	Katz ADL, mean (SD)	Mean diff (95% CI)	P value	Adj B coef (95% CI)	Adj P value
Baseline	DHS	0.81 (1.64)	− 0.88 (− 1.66;− 0.09)	0.029	− 0.04 (− 0.88 to 0.60)	0.90
Baseline	PFNA	1.68 (2.00)	− 0.88 (− 1.66;− 0.09)	0.029	− 0.04 (− 0.88 to 0.60)	0.90
6 weeks	DHS	1.95 (1.96)	− 0.06 (− 1.00 to 0.88)	0.90	− 0.52 (− 1.41 to 0.36)	0.25
6 weeks	PFNA	2.02 (1.86)	− 0.06 (− 1.00 to 0.88)	0.90	− 0.52 (− 1.41 to 0.36)	0.25
3 months	DHS	1.86 (1.95)	− 0.16 (− 1.20 to 0.87)	0.76	− 0.47 (− 1.41 to 0.474)	0.33
3 months	PFNA	1.85 (2.01)	− 0.16 (− 1.20 to 0.87)	0.76	− 0.47 (− 1.41 to 0.474)	0.33
1 year	DHS	1.20 (1.85)	− 0.63 (− 1.56 to 0.31)	0.19	− 0.08 (− 0.91 to 0.76)	0.86
1 year	PFNA	1.83 (2.03)	− 0.63 (− 1.56 to 0.31)	0.19	− 0.08 (− 0.91 to 0.76)	0.86

Adjusted repeated measure coefficient estimate: 0.27; 95% C − 0.52 to 1.06; P = 0.50. Italics indicate statistical significance (P < 0.05), ADL activities of daily living, SD standard deviation, Diff difference, Adj adjusted, Coef coefficient